GABRA2 and the Pharmacokinetics of Risk for Alcoholism (GPRA)

Completed · Not applicable · Has a placebo group

Conditions studied: Alcoholism

In brief

This study will assess whether the presence of a particular form of a gene, GABRA2, affects the functional responses of the human brain to alcohol administration and will evaluate that relationship in the context of factors known to increase the risk for future alcoholism.

Key facts

Study ID
NCT00681655
Run by
Indiana University
People needed
141
Starts
2008-05-01
Expected to finish
2012-04-14
Last updated by the study team
2022-04-07

Who can join

Age: 21 and older, up to 27. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.